From: miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
Variable | No. of patients | miR181 expression | p (χ2) | NOTCH2 expression | p (χ2) | CD133 expression | p (χ2) | SOX2 expression | p (χ2) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High (n) | Low (n) | (−) (n) | (+) (n) | (++) (n) | (+++) (n) | (−) (n) | (+) (n) | (++) (n) | (+++) (n) | (−) (n) | (+) (n) | (++) (n) | (+++) (n) | ||||||
All cases | 116 | 57 | 59 | Â | 24 | 33 | 27 | 32 | Â | 3 | 43 | 61 | 9 | Â | 8 | 14 | 40 | 54 | Â |
Age (years) | Â | Â | Â | 0.196 | Â | Â | Â | Â | 0.356 | Â | Â | Â | Â | 0.828 | Â | Â | Â | Â | 0.324 |
 ≤ 55 | 35 | 14 | 21 |  | 8 | 6 | 10 | 11 |  | 1 | 15 | 17 | 2 |  | 2 | 5 | 8 | 20 |  |
 > 55 | 81 | 43 | 38 |  | 16 | 27 | 17 | 21 |  | 2 | 28 | 44 | 7 |  | 6 | 9 | 32 | 34 |  |
Gender | Â | Â | Â | 0.578 | Â | Â | Â | Â | 0.595 | Â | Â | Â | Â | 0.239 | Â | Â | Â | Â | 0.782 |
 Male | 89 | 45 | 44 |  | 16 | 27 | 21 | 25 |  | 3 | 31 | 46 | 9 |  | 6 | 12 | 29 | 42 |  |
 Female | 27 | 12 | 15 |  | 8 | 6 | 6 | 7 |  | 0 | 12 | 15 | 0 |  | 2 | 2 | 11 | 12 |  |
Differentiation | Â | Â | Â | 0.684 | Â | Â | Â | Â | 0.002 | Â | Â | Â | Â | 0.015 | Â | Â | Â | Â | 0.044 |
 Good/moderate | 20 | 9 | 11 |  | 10 | 4 | 5 | 1 |  | 2 | 11 | 7 | 0 |  | 2 | 5 | 9 | 4 |  |
 Poor | 96 | 48 | 48 |  | 14 | 29 | 22 | 31 |  | 1 | 32 | 54 | 9 |  | 6 | 9 | 31 | 50 |  |
pT status | Â | Â | Â | 0.761 | Â | Â | Â | Â | 0.226 | Â | Â | Â | Â | 0.096 | Â | Â | Â | Â | 0.486 |
 pT1 | 20 | 11 | 9 |  | 5 | 7 | 5 | 3 |  | 2 | 10 | 6 | 2 |  | 1 | 1 | 11 | 7 |  |
 pT2 | 84 | 41 | 43 |  | 19 | 20 | 21 | 24 |  | 1 | 27 | 49 | 7 |  | 6 | 12 | 26 | 40 |  |
 pT3–4 | 12 | 5 | 7 |  | 0 | 5 | 1 | 5 |  | 0 | 6 | 6 | 0 |  | 1 | 1 | 3 | 7 |  |
pN stage | Â | Â | Â | 0.005 | Â | Â | Â | Â | 0.186 | Â | Â | Â | Â | 0.109 | Â | Â | Â | Â | 0.004 |
 pN0 | 85 | 49 | 35 |  | 18 | 29 | 18 | 20 |  | 1 | 31 | 44 | 9 |  | 2 | 11 | 30 | 42 |  |
 pN1 | 14 | 3 | 11 |  | 1 | 3 | 4 | 6 |  | 0 | 5 | 9 | 0 |  | 1 | 2 | 3 | 8 |  |
 pN2 | 17 | 5 | 13 |  | 5 | 1 | 5 | 6 |  | 2 | 7 | 8 | 0 |  | 5 | 1 | 7 | 4 |  |
pTNM stage | Â | Â | Â | 0.022 | Â | Â | Â | Â | 0.186 | Â | Â | Â | Â | 0.055 | Â | Â | Â | Â | 0.131 |
 I | 65 | 34 | 31 |  | 13 | 23 | 15 | 14 |  | 1 | 23 | 32 | 9 |  | 2 | 8 | 25 | 30 |  |
 II | 26 | 7 | 19 |  | 6 | 8 | 4 | 8 |  | 0 | 9 | 17 | 0 |  | 1 | 4 | 6 | 15 |  |
 III | 25 | 16 | 9 |  | 5 | 2 | 8 | 10 |  | 2 | 11 | 12 | 0 |  | 5 | 2 | 9 | 9 |  |